Rifaximin for active ulcerative colitis

Inflamm Bowel Dis. 2006 Apr;12(4):335. doi: 10.1097/01.MIB.0000215092.85116.6c.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Aged
  • Colitis, Ulcerative / drug therapy*
  • Dose-Response Relationship, Drug
  • Female
  • Follow-Up Studies
  • Gastrointestinal Agents / administration & dosage
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Remission Induction
  • Rifamycins / administration & dosage
  • Rifamycins / therapeutic use*
  • Rifaximin
  • Treatment Outcome

Substances

  • Gastrointestinal Agents
  • Rifamycins
  • Rifaximin